WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Sunday, April 26, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


The opportunity within the DNA Encoded Library Market to grow at 16% CAGR till 2035, according to a market research report by Roots Analysis
Wednesday, September 13, 2023

In recent years, there has been a growth in the use of DNA encoded libraries, driven by several technological advancements and the growing demand for effective techniques for screening of potential drug targets

LONDON, Sept. 5, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "DNA Encoded Library Market, 2023-2035" report to its list of offerings.

Owing to its access to the largest chemical space available in the market, DNA encoded chemical library platforms are a natural fit for big data analytics and modeling technologies offered by artificial intelligence and machine learning. As a result, some companies have been pursuing this opportunity by integrating artificial intelligence and machine learning in DNA encoded libraries, including Insitro, a leading player in machine learning for drug discovery, which acquired Haystack Sciences in 2020. Insitro made the acquisition to leverage Haystack Sciences DNA sequencing technology to enhance its machine learning based drug discovery capability. Additionally, Google Research also collaborated with X-Chem in 2020 to develop an effective method for finding biologically active molecules using physical and virtual screening. Further, in 2021, Relay Therapeutics acquired ZebiAI for USD 85 million upfront, allowing them to incorporate the machine learning based DNA encoded chemical library technology into their protein targeting platform, Dynamo.

To order this 275+ page report, which features 130+ figures and 145+ tables, please check our DNA Encoded Library Market Report

Key Market Insights

    --  Presently, around 50 companies claim to offer DNA encoded libraries and
        affiliated services for drug discovery across different regions of the
        world; majority of the players are based in the US
    --  Leveraging their expertise, stakeholders are offering DNA encoded
        libraries for a myriad of drug discovery services; around 70% of the
        companies provides different type of library screening services
    --  Majority of the companies engaged in this field of research are based in
        the developed geographies; the market landscape is fragmented, featuring
        the presence of both small firms and established players
    --  Stakeholders have adopted various business models to maximize the gain
        from DNA encoded libraries; a significant number of in-house players
        have started out-licensing their DNA encoded library platforms
    --  In pursuit of building a competitive edge, stakeholders are actively
        upgrading their existing capabilities to enhance their respective
        service offerings and comply with the evolving industry benchmarks
    --  The growing interest in this domain is evident from the rise in
        partnership activity; in fact, the maximum number of collaborations
        related to DNA encoded libraries were inked in 2021
    --  Several investors, having realized the opportunity within this domain,
        have invested over USD 4 billion across various funding rounds in the
        past six years
    --  More than 400 patents have been filed / granted by various stakeholders
        in order to protect the intellectual property generated within this
        field since 2005
    --  Big pharma players have undertaken several initiatives, ranging from
        proprietary library development to strategic investments, to tap the
        lucrative opportunity in this rapidly growing market
    --  With an objective to provide support to DNA encoded libraries focused
        companies / organization, several stakeholders are deploying diverse
        support services as well as ancillary tools
    --  In the short term, the opportunity is likely to be driven by library
        platform licensing activity; this activity is likely to increase as the
        industry realizes the capability of DNA encoded libraries to discover
        high-value therapeutic leads
    --  The market is expected to grow at an annualized rate of 16% between
        2023-2035; the projected opportunity is anticipated to be well
        distributed across various market segments

For additional details, please check out our report on DNA Encoded Library Market

The financial opportunity within the DNA encoded library market has been analyzed across the following segments:

    --  Application Area
        --  Hit Generation / Identification
        --  Hit to Lead
        --  Hit Validation / Optimization
        --  Other Application Areas
    --  Therapeutic Area
        --  Oncological Disorders
        --  Immunological Disorders
        --  Neurological Disorders
        --  Respiratory Disorders
        --  Dermatological Disorders
        --  Cardiovascular Disorders
        --  Infectious Diseases
        --  Other Therapeutic Areas
    --  End-user
        --  Pharma / Biopharma Industry
        --  Academic / Research Institute
        --  Other End-users
    --  Type of Payment Model Employed
        --  Upfront Payment
        --  Milestone Payment
    --  Key Geographical Regions
        --  North America
        --  Europe
        --  Asia-Pacific

The opinions and insights presented in this report were also influenced by discussions held with eminent stakeholders in this industry. The report features detailed transcripts of interviews held with the following industry stakeholders:

    --  Nils Jakob Vest Hansen (Chief Executive Officer, Vipergen)
    --  Thorsten Genski (Chief Executive Officer, Serengen)
    --  Thomas Kodadek (Co-Founder, Deluge Biotechnologies) and Ofelia Utset
        (President, Deluge Biotechnologies)
    --  Frank Moffatt (Director of Business Development, NovAliX)
    --  Christos Tsiamantas (Senior Scientist, Orbit Discovery)

The research also includes detailed profiles of key players (listed below) that offer DNA encoded library platforms and services; each profile features a brief overview of the company, its financial information (if available), details on platform and service portfolio, recent developments and an informed future outlook.

    --  AlphaMa
    --  DICE Therapeutics
    --  DyNAbind
    --  HitGen
    --  NovAliX
    --  Vipergen
    --  WuXi AppTec
    --  X-Chem

Key Questions Answered

    --  What is a DNA encoded library?
    --  What is DNA encoded library screening?
    --  How are DNA encoded libraries made?
    --  How is information encoded in DNA?
    --  How DNA encoded libraries are revolutionizing drug discovery?
    --  What are the advantages of DNA encoded library?
    --  How many companies are developing DNA encoded libraries?
    --  Which type of business model is widely adopted by companies in DNA
        encoded library market?
    --  What is the current landscape of patents filed for DNA encoded
        libraries?
    --  Who are the key players in the DNA encoded library market?
    --  What are the leading market segments in the global DNA encoded library
        market?
    --  Which region captures the largest share in the DNA encoded library
        market?
    --  What is the likely growth rate (CAGR) for DNA encoded library market?

Table of Contents

    1. Preface
    2. Executive Summary
    3. Introduction
    4. Market Landscape
    5. Business Model Analysis
    6. Company Competitiveness Analysis
    7. Company Profiles
    8. Partnerships and Collaborations
    9. Global Event Analysis
    10. Patent Analysis
    11. Big Pharma Initiatives

    12. Case Study: Companies / Organizations Supporting the Development of DNA
        Encoded       Libraries
    13. Market Forecast and Opportunity Analysis
    14. Concluding Remarks
    15. Executive Insights
    16. Appendix 1: Tabulated Data
    17. Appendix 2: List of Companies and Organizations

For additional details, please visit https://www.rootsanalysis.com/reports/dna-encoded-libraries/288.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

1. Lab Automation Market, 2023-2035

2. Deep Learning in Drug Discovery Market and Deep Learning in Diagnostics Market, 2023-2035

3. Quantum Computing Market in Drug Discovery, 2023-2035

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-opportunity-within-the-dna-encoded-library-market-to-grow-at-16-cagr-till-2035-according-to-a-market-research-report-by-roots-analysis-301916992.html

SOURCE Roots Analysis



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
Nav Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
Nav DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
Nav Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
Nav Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
Nav Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
Nav Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
Nav Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
Nav The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
Nav Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News